Ultragenyx Pharmaceutical Inc. - Common Stock — Financial Statistics (NASDAQ:RARE) | MetaTrader

Open full chart

News

RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos

Ultragenyx Nabs FDA Nod for First Gene Therapy - Ultragenyx Pharmaceutical (NASDAQ:RARE)

Okta To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday - Moderna (NASDAQ:MRNA), Merc

Ultragenyx Pharmaceutical Inc. (RARE) Discusses FDA Approval of Gene Therapy for Glycogen Storage Disease Type 1a Transcript

Prime Medicine: An Initial Prognosis (NASDAQ:PRME)

Binance will add monitoring tags for GLMR, ICX, MOVR, RARE, and SOPH

Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y

Ultragenyx Pharmaceutical Inc. (RARE) Q2 2026 Earnings Call Transcript

Ultragenyx (RARE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates

Tarsus Pharmaceuticals, Inc. (TARS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Earnings Preview: Ultragenyx (RARE) Q2 Earnings Expected to Decline